Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
An Bras Dermatol ; 93(2): 238-241, 2018 03.
Article in English | MEDLINE | ID: mdl-29723354

ABSTRACT

BACKGROUND: Topical agents used in combination with phototherapy or photochemotherapy may have both blocking or enhancing effects in ultraviolet rays. OBJECTIVE: In this in vivo study, the effects of topical petrolatum, basis cream, glycerine, and olive oil on the transmission of ultraviolet A radiation were investigated. METHODS: A test was performed to determine the minimal phototoxic dose on 29 volunteers with only psoralen plus ultraviolet A (PUVA) and then the same test was repeated with white petrolatum, basis cream, glycerine, olive oil, and sunscreen (0.3cc/25cm2). The effects of each agent on the minimal phototoxic dose were determined after 72 h. RESULTS: When compared to pure PUVA, there was a statistically significant increase in the mean minimal phototoxic dose values by the application of white petrolatum (P = 0.011), but there was no significant increase or decrease in the mean minimal phototoxic dose values after the application of basis cream (P = 0.326), glycerine (P = 0.611) or olive oil (P = 0.799). STUDY LIMITATIONS: Low number of patients Conclusion: The application of white petrolatum, which has a blocking effect, and also of basis cream immediately before PUVA therapy should not be recommended. Although we specify that glycerine and maybe olive oil can be used before photochemotherapy, there is a need for further research in larger series.


Subject(s)
Emollients/pharmacology , PUVA Therapy/methods , Petrolatum/pharmacology , Photochemotherapy/methods , Photosensitizing Agents/pharmacology , Skin Diseases/drug therapy , Ultraviolet Rays , Dermatitis, Phototoxic/prevention & control , Dose-Response Relationship, Radiation , Glycerol/pharmacology , Humans , Olive Oil/pharmacology , Reproducibility of Results , Single-Blind Method , Skin Tests , Statistics, Nonparametric , Sunscreening Agents/pharmacology , Time Factors , Treatment Outcome
2.
An. bras. dermatol ; 93(2): 238-241, Mar.-Apr. 2018. tab, graf
Article in English | LILACS | ID: biblio-887175

ABSTRACT

Abstract: Background: Topical agents used in combination with phototherapy or photochemotherapy may have both blocking or enhancing effects in ultraviolet rays. Objective: In this in vivo study, the effects of topical petrolatum, basis cream, glycerine, and olive oil on the transmission of ultraviolet A radiation were investigated. Methods: A test was performed to determine the minimal phototoxic dose on 29 volunteers with only psoralen plus ultraviolet A (PUVA) and then the same test was repeated with white petrolatum, basis cream, glycerine, olive oil, and sunscreen (0.3cc/25cm2). The effects of each agent on the minimal phototoxic dose were determined after 72 h. Results: When compared to pure PUVA, there was a statistically significant increase in the mean minimal phototoxic dose values by the application of white petrolatum (P = 0.011), but there was no significant increase or decrease in the mean minimal phototoxic dose values after the application of basis cream (P = 0.326), glycerine (P = 0.611) or olive oil (P = 0.799). Study limitations: Low number of patients Conclusion: The application of white petrolatum, which has a blocking effect, and also of basis cream immediately before PUVA therapy should not be recommended. Although we specify that glycerine and maybe olive oil can be used before photochemotherapy, there is a need for further research in larger series.


Subject(s)
Humans , Petrolatum/pharmacology , Photochemotherapy/methods , PUVA Therapy/methods , Skin Diseases/drug therapy , Ultraviolet Rays , Photosensitizing Agents/pharmacology , Emollients/pharmacology , Sunscreening Agents/pharmacology , Time Factors , Skin Tests , Single-Blind Method , Reproducibility of Results , Treatment Outcome , Dermatitis, Phototoxic/prevention & control , Statistics, Nonparametric , Dose-Response Relationship, Radiation , Olive Oil/pharmacology , Glycerol/pharmacology
3.
J Immunol Res ; 2015: 258430, 2015.
Article in English | MEDLINE | ID: mdl-26380315

ABSTRACT

Psoriasis is a chronic, recurrent, immune-mediated inflammatory disease and it can be provoked or exacerbated by a variety of different environmental factors, particularly infections and drugs. In addition, a possible association between vaccination and the new onset and/or exacerbation of psoriasis has been reported by a number of different authors. The aim of this study is to investigate the effects of influenza vaccination on patients with psoriasis. Here, we report the findings from 43 patients suffering from psoriasis (clinical phenotypes as mixed guttate/plaque lesions, palmoplantar or scalp psoriasis) whose diseases had been triggered after influenza vaccination applied in the 2009-2010 season. The short time intervals between vaccination and psoriasis flares in our patients and the lack of other possible triggers suggest that influenza vaccinations may have provocative effects on psoriasis. However, further large and controlled studies need to be carried out to confirm this relationship.


Subject(s)
Influenza Vaccines/adverse effects , Psoriasis/etiology , Vaccination/adverse effects , Female , Humans , Influenza Vaccines/immunology , Alphainfluenzavirus/classification , Alphainfluenzavirus/immunology , Male , Psoriasis/diagnosis , T-Lymphocyte Subsets/immunology , Time Factors
5.
Photodermatol Photoimmunol Photomed ; 26(2): 101-3, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20415743

ABSTRACT

We report on a 35-year-old woman with cutaneous lesions characterized by an erythema multiforme-like appearance localized in the photo-distributed pattern. She had no history of systemic drug ingestion, herpes simplex virus or any other infection, possible causes of erythema multiforme, before the sun exposure. She had normal tolerance to a phototest, but photoprovocation tests could not be performed because she did not agree to them. This case was diagnosed to be an erythema multiforme-like variant of a polymorphous light eruption; the differential diagnosis of target-like lesions in a photo-distributed pattern is discussed.


Subject(s)
Erythema Multiforme/diagnosis , Photosensitivity Disorders/diagnosis , Sunlight/adverse effects , Adult , Diagnosis, Differential , Erythema Multiforme/pathology , Female , Humans , Photosensitivity Disorders/pathology
8.
Int J Dermatol ; 45(6): 709-12, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16796633

ABSTRACT

BACKGROUND: Clinical and histopathological differential diagnosis is usually impossible in drug-induced lichen planus (LP) and idiopathic LP. Naproxen is a nonsteroidal anti-inflammatory drug, which is widely used for its analgesic, antipyretic and anti-inflammatory effects. To the best of our knowledge, two case reports on naproxen-induced LP have been reported. METHODS: Fifty-five patients with LP, and a history of naproxen intake before their eruption, were investigated. RESULTS: Twenty-five patients (45.5%) had a history of naproxen intake prior to their eruption without any other medication. Twelve patients (21.8%) had a history of simultaneous use of naproxen with other drugs that were reported as inducers of LP. Eighteen patients (32.7%) had given a history of using naproxen together with drugs that had not been previously reported as inducers of LP. Moreover, in 42 patients, eruptive-type LP development after naproxen intake, is an interesting observation. New lesions were not observed after the cessation of naproxen intake in any of the patients. CONCLUSION: Naproxen might be accepted as an important inducer for LP, especially for the eruptive form.


Subject(s)
Lichen Planus/chemically induced , Naproxen/adverse effects , Adolescent , Aged , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Child, Preschool , Diagnosis, Differential , Drug Therapy, Combination , Female , Humans , Lichen Planus/diagnosis , Lichen Planus/pathology , Lichen Planus/physiopathology , Male , Middle Aged
9.
J Dermatol ; 33(4): 252-5, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16674788

ABSTRACT

Angioma serpiginosum is a rare benign vascular disorder, characterized clinically by multiple minute, red to purple, grouped macules in serpiginous and gyrate patterns and histopathologically by ectatic dilatation of capillaries. Patients can undergo unnecessary hematological tests, because the condition can be confused with chronic purpuric dermatoses. An 18-year-old man with angioma serpiginosum of his left arm was evaluated by dermoscopy and treated with pulsed dye laser. Numerous small, relatively well-demarcated, round to oval red lagoons were determined with dermoscopy, and approximately 75% of the area of his lesion disappeared after four sessions of pulsed dye laser. Our case supports the hypothesis that dermoscopy is beneficial in the diagnosis of angioma serpiginosum and that pulsed dye laser is effective in the treatment of this disorder.


Subject(s)
Hemangioma/pathology , Hemangioma/radiotherapy , Skin Neoplasms/pathology , Skin Neoplasms/radiotherapy , Adolescent , Dermoscopy , Humans , Low-Level Light Therapy , Male
10.
Eur J Dermatol ; 16(3): 287-9, 2006.
Article in English | MEDLINE | ID: mdl-16709496

ABSTRACT

Peeling skin syndrome is a rare disease characterized by widespread painless peeling of the skin. To date, several cases have been described with different clinical features called peeling skin syndrome. Previous reports describe two types (type A and type B) of peeling skin syndrome, both of which show generalized desquamation, sparing palms and soles. We report a 23-year old man who has been classified as neither type A nor type B, and whose history, clinical features and histopathological findings led to a diagnosis of peeling skin syndrome. In addition, the desquamation pattern in our patient was different from that of both types because our case's palms and soles were involved too.


Subject(s)
Hand Dermatoses/diagnosis , Adult , Hand Dermatoses/pathology , Humans , Male
11.
Photodermatol Photoimmunol Photomed ; 22(3): 137-40, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16719867

ABSTRACT

BACKGROUND/PURPOSE: Various topical agents which can be used in combination with phototherapy may have blocking or enhancing effects. In this in vivo study, the effects of topical petrolatum, basis cream, glycerine and olive oil on the transmission of ultraviolet B (UVB) were investigated. METHODS: A phototest was performed to determine the minimal erythema dose (MED) on 32 volunteers and the test was repeated with white petrolatum, basis cream, glycerine, olive oil and sunscreen (0.3 cm3/25 cm2). The effects of each agent on MED was determined after 24 h. RESULTS: MEDs were increased with the application of white petrolatum and basis cream. However, MEDs were not changed with the application of glycerine and olive oil. CONCLUSION: The application of white petrolatum and basis cream, which have blocking effects, immediately before UVB therapy is not recommended. However, glycerine and olive oil, which does not have any effect, can be used before phototherapy.


Subject(s)
Emollients/chemistry , Photosensitizing Agents/chemistry , Sunscreening Agents/chemistry , Ultraviolet Rays , Dose-Response Relationship, Radiation , Emollients/pharmacology , Erythema/etiology , Female , Humans , Male , Photosensitizing Agents/pharmacology , Single-Blind Method , Skin Tests/methods , Sunscreening Agents/pharmacology , Ultraviolet Therapy/adverse effects , Ultraviolet Therapy/methods
12.
Eur J Dermatol ; 16(2): 146-50, 2006.
Article in English | MEDLINE | ID: mdl-16581565

ABSTRACT

Although papulopustular lesions are common in patients with Behçet's disease (BD), clinically they may not be differentiated from other diseases with papulopustular presentation such as acne vulgaris or folliculitis. Therefore, there is disagreement as to whether they should be used as a diagnostic criterion in BD. The aim of this study was to determine whether the histopathologic evaluation of the papulopustular lesions may assist in the diagnosis of BD. Eighteen patients with BD and 16 control patients consisting of eleven patients with bacterial folliculitis and five patients with acne vulgaris were included in the study. After the detailed histopathologic evaluation by two pathologists who were blinded to the clinical diagnoses, the histopathologic findings were classified into three patterns as follows; pattern I: vasculitis (lymphocytic or leucocytoclastic); pattern II: folliculitis and/or perifolliculitis; pattern III: superficial and/or deep perivascular, and/or interstitial dermatitis. In addition, direct immunofluorescence studies were performed in order to evaluate the deposition of IgM, IgG, IgA, C3, or fibrinogen in dermal blood vessels. 27.8% of the patients with BD (5 patients) revealed lymphocytic vasculitis, while none of the control group did; and the difference was found statistically significant (P=0.046). The rate of pattern II which included folliculitis and/or perifolliculitis was 50.0% in control patients and 16.7% in the patients with BD; and the difference was found statistically significant (P=0.038). No difference was found between the two groups with regard to pattern III or direct immunofluorescence findings (P>0.05). Our results indicate that only vasculitic changes can be useful when histopathological features of papulopustular lesions are to be employed as a diagnostic criterion in patients with suspected BD.


Subject(s)
Behcet Syndrome/complications , Behcet Syndrome/pathology , Fluorescent Antibody Technique, Direct , Skin Diseases, Vesiculobullous/etiology , Skin Diseases, Vesiculobullous/pathology , Adult , Female , Humans , Male , Middle Aged
13.
J Dermatol ; 32(11): 868-74, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16361746

ABSTRACT

Various studies have shown the blocking effects of topical agents on UVB penetration, which can be used in combination with phototherapy. In this study, the photoprotective effects of 0.005% calcipotriol, 0.05% clobetasol-17-propionate, and 0.1% tretinoin, which can be used in combination with broad-band UVB, were investigated in an in vivo test. In a study group of 20 patients, phototests were performed to determine minimal erythema doses (MED) and the tests were repeated with thin (0.1 cc/25 cm2) and thick (0.3 cc/25 cm2) calcipotriol, clobetasol-17-propionate, and tretinoin in cream forms and sunscreen. After determining the MED, the test was repeated in another 20 patients with thin and thick calcipotriol and clobetasol-17-propionate in both cream and ointment forms and sunscreen. MED was increased with thin and thick applications of all agents. Moreover, the photoprotective effects of each agent increased with their thick applications compared with thin ones. The application of calcipotriol cream and ointment, clobetasol cream and ointment, and tretinoin cream, all of which can block UVB, is not recommended just before phototherapy.


Subject(s)
Calcitriol/analogs & derivatives , Clobetasol/analogs & derivatives , Dermatologic Agents/therapeutic use , Erythema/prevention & control , Tretinoin/therapeutic use , Ultraviolet Rays , Adult , Calcitriol/therapeutic use , Clobetasol/therapeutic use , Erythema/etiology , Humans , Ointments , Reference Values , Single-Blind Method
14.
J Dermatol ; 32(5): 361-4, 2005 May.
Article in English | MEDLINE | ID: mdl-16043898

ABSTRACT

Infectious agents, especially viruses, have been implicated in the pathogenesis of Behçet's disease (BD). The aim of this study was to determine whether BD is associated with hepatitis viruses. In this study, the serological markers of hepatitis (HBsAg, anti-HBs, anti-HBc and anti-HCV) and viral nucleic acid (HGV-RNA) were studied in the sera of 35 patients, all of whom fulfilled the diagnostic criteria of the International Study Group for BD, and the results were compared with those of 36 healthy controls. The prevalences of HBsAg, anti-HBs, anti-HBc in BD patients were 2.9%, 45.7%, and 31.4%, respectively, which were not significantly different from those in healthy controls. None of the subjects in either group were found to be positive for anti-HCV. HGV-RNA was detected in two patients with BD and in none of the healthy controls. In conclusion, BD does not seem to be associated with hepatitis viral infections including hepatitis B, C, or G.


Subject(s)
Behcet Syndrome/diagnosis , Behcet Syndrome/virology , GB virus C/isolation & purification , Hepacivirus/isolation & purification , Hepatitis B virus/isolation & purification , Hepatitis, Viral, Human/diagnosis , Behcet Syndrome/epidemiology , Behcet Syndrome/physiopathology , Case-Control Studies , DNA, Viral/analysis , Female , Flaviviridae Infections/diagnosis , Flaviviridae Infections/epidemiology , Hepatitis B/diagnosis , Hepatitis B/epidemiology , Hepatitis C/diagnosis , Hepatitis C/epidemiology , Hepatitis, Viral, Human/epidemiology , Humans , Male , Prevalence , Probability , Reference Values , Risk Assessment , Sensitivity and Specificity , Severity of Illness Index
15.
J Dermatol ; 31(11): 884-9, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15729860

ABSTRACT

Clinical differentiation of facial lentigo senilis/initial seborrheic keratosis (LS/ISK), seborrheic keratosis (SK), lentigo maligna (LM), and lentigo maligna melanoma (LMM) can be difficult. Dermoscopy improves the diagnoses in pigmented skin lesions (PSLs), but it is not helpful for the sun-exposed face because of the flat rete ridges without network-derived features. Therefore, development of new diagnostic criteria for this particular localization is a current issue of dermatology. In this retrospective study, dermoscopic slides of facial pigmented skin lesions of 66 patients referred to two clinics in Turkey were evaluated. Our aim was to determine the reliability of dermoscopy in the differentiation of these entities. The facial PSLs of 66 patients (34 males and 32 females) (median age: 58.2) were photographed with a Dermaphot (Heine, Hersching, Germany) over a five year period from November of 1995 to May of 2000. All of the dermoscopic slides were analysed according to 27 dermoscopic criteria developed by Schiffner et al. This data set contained 22 histologically proven malignant (14 LM, 8 early LMM) and 44 benign (18 SK, 26 LS/ISK) PSLs. In general, asymmetric pigmented follicular openings, dark streaks, slate-gray streaks, dark globules, slate-gray globules, dark dots, dark rhomboidal structures, light brown rhomboidal structures, dark homogeneous areas and dark pseudonetworks were statistically significant for malignant growth. On the other hand, milia-like cysts, pseudofollicular openings, cerebriform structures, light brown globules, light brown dots, light brown homogeneous areas, yellow opaque homogeneous areas, and light brown pseudonetworks were statistically significant for benign growth. This research emphasizes that dermoscopic features on the face differ from criteria used in other locations of the body. Analysis of the data suggests that dermoscopy can be used in the differentiation of LS/ISK, SK, LM and LMM from each other.


Subject(s)
Dermoscopy/methods , Facial Dermatoses/diagnosis , Facial Neoplasms/diagnosis , Hutchinson's Melanotic Freckle/diagnosis , Keratosis, Seborrheic/diagnosis , Lentigo/diagnosis , Melanoma/diagnosis , Color , Diagnosis, Differential , Epidermal Cyst/pathology , Facial Dermatoses/pathology , Facial Neoplasms/pathology , Female , Hair Follicle/pathology , Humans , Hutchinson's Melanotic Freckle/pathology , Keratosis, Seborrheic/pathology , Lentigo/pathology , Male , Melanoma/pathology , Middle Aged , Photography , Reproducibility of Results , Retrospective Studies , Skin Pigmentation
16.
Dermatol Surg ; 29(10): 1066-7, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12974707

ABSTRACT

BACKGROUND: Pilomatricomas, which are usually solitary, firm to hard tumors that are covered by normal skin, rarely show a bullous appearance. OBJECTIVE: To discuss, through a case report, the clinical and histopathologic characteristics of bullous pilomatricomas. METHODS: A 15-year-old boy presented with a firm, well-defined tumor on his right arm that showed dark-blue discoloration and bullous formation over it. RESULTS: Excisional biopsy was performed, and histopathologic examination confirmed the diagnosis of bullous pilomatricoma. CONCLUSION: The presence of dilated lymphatics, also seen in our patient, is a common feature of bullous pilomatricomas.


Subject(s)
Blister/pathology , Hair Diseases/pathology , Pilomatrixoma/pathology , Skin Neoplasms/pathology , Skin/pathology , Adolescent , Biopsy , Humans , Male
19.
Eur J Dermatol ; 12(2): 154-6, 2002.
Article in English | MEDLINE | ID: mdl-11872412

ABSTRACT

Various topical agents used in combination with phototherapy have blocking effects, however in contrast to in vitro studies there were not enough in vivo studies about this subject. Our purpose was to examine the photoprotective effects of white petrolatum and salicylic acid which can be used before UVB therapy in psoriasis patients. In 35 volunteers, a phototest was performed to determine the minimal erythema dose (MED) and the test was repeated with thin (0.1 cc/25 cm2) and thick (0.3 cc/25 cm2) petrolatum, thin and thick salicylic acid (20%) in petrolatum and sunscreen. After 24 hrs, the effects of each agent on MED was investigated. MED values detected after pure UVB and after application of topical agents were compared one by one, and the differences between all of them have been found statistically significant. These showed that MED values were increased by thin or thick petrolatum and also by thin and thick salicylic acid (20%) in petrolatum. The highest MED values were detected with thick salicylic acid in petrolatum followed by thin salicylic acid in petrolatum, thick petrolatum and thin petrolatum. The application of petrolatum and salicylic acid, which can block UVB, before phototherapy is not recommended.


Subject(s)
Emollients/chemistry , Keratolytic Agents/chemistry , Petrolatum/chemistry , Psoriasis/radiotherapy , Salicylic Acid/chemistry , Ultraviolet Therapy/methods , Emollients/administration & dosage , Erythema/etiology , Humans , Keratolytic Agents/administration & dosage , Petrolatum/administration & dosage , Salicylic Acid/administration & dosage , Single-Blind Method , Skin/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...